Immunoassays are used routinely in NBS as a first-tier screening protocol, therefore the multiplex immunoassay presents as a viable alternative or complement to the TREC assay in detecting SCID.Low cost rapid test (Immunoassay vs. DNA testing)For markets where DNA/TREC Assay testing equipment is not.....
[更多]
Scientists at UC San Diego have addressed these shortcomings and developed a high-content, high-throughput chemical screening method that is based on a signature of gene expression. This signature-based drug screening strategy overcomes key drawbacks associated with current cell-based assays. The pr.....
[更多]
| |< <- | [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] |
